- Home
- SBFM vs VANI Comparison
SBFM vs VANI Comparison
Compare SBFM & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- VANI
- Stock Information
- Founded
- SBFM 2006
- VANI 1998
- Country
- SBFM United States
- VANI United States
- Employees
- SBFM N/A
- VANI N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SBFM Health Care
- VANI Health Care
- Exchange
- SBFM Nasdaq
- VANI Nasdaq
- Market Cap
- SBFM 6.6M
- VANI 68.1M
- IPO Year
- SBFM N/A
- VANI 2014
- Fundamental
- Price
- SBFM $1.50
- VANI $1.27
- Analyst Decision
- SBFM Strong Buy
- VANI Strong Buy
- Analyst Count
- SBFM 1
- VANI 1
- Target Price
- SBFM $15.00
- VANI $4.00
- AVG Volume (30 Days)
- SBFM 188.7K
- VANI 139.6K
- Earning Date
- SBFM 08-15-2025
- VANI 08-12-2025
- Dividend Yield
- SBFM N/A
- VANI N/A
- EPS Growth
- SBFM N/A
- VANI N/A
- EPS
- SBFM N/A
- VANI N/A
- Revenue
- SBFM $36,234,578.00
- VANI N/A
- Revenue This Year
- SBFM $192.48
- VANI N/A
- Revenue Next Year
- SBFM N/A
- VANI N/A
- P/E Ratio
- SBFM N/A
- VANI N/A
- Revenue Growth
- SBFM 35.51
- VANI N/A
- 52 Week Low
- SBFM $1.17
- VANI $0.91
- 52 Week High
- SBFM $7.60
- VANI $1.50
- Technical
- Relative Strength Index (RSI)
- SBFM 50.10
- VANI 60.41
- Support Level
- SBFM $1.43
- VANI $1.24
- Resistance Level
- SBFM $1.75
- VANI $1.30
- Average True Range (ATR)
- SBFM 0.11
- VANI 0.06
- MACD
- SBFM 0.00
- VANI -0.00
- Stochastic Oscillator
- SBFM 30.56
- VANI 63.64
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.